drugset / Trial / NCT04539379

Evaluation of Intravenous Infusion of Labetalol Versus Magnesium Sulfate

NCT04539379

Completed 60 enrolled Zagazig University
RandomizedParallel-groupDouble-blindTreatment

Summary

the purpose of this study is to compare Intravenous infusion of Labetalol versus Magnesium Sulfate on Cerebral Hemodynamics of Severe Preeclampsia Patients using Transcranial Doppler

Timeline

Start
2020-10-01
Primary completion
2022-02-01
Completion
2022-03-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Labetalol Small molecule 20 mg Intravenous
Comparator Magnesium Sulfate Other / unclassified 1 g Intravenous

Indications

No indication recorded.